Routine BRCA testing for ovarian cancer: a game changer in the making?
NCT ID NCT06274541
First seen Apr 18, 2026 · Last updated May 15, 2026 · Updated 6 times
Summary
This study looked at whether it's practical to routinely test tumor tissue from ovarian cancer patients for BRCA gene mutations. Researchers enrolled 200 patients with high-grade serous or endometrioid ovarian, fallopian tube, or primary peritoneal cancer. The goal was to see if this testing could be done smoothly in the clinic and how it might affect treatment choices and costs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bon Secours
Cork, Munster, Ireland
-
Cork University Hospital
Cork, Munster, Ireland
-
Mater Misericordiae University Hospital / Mater Private Hospital
Dublin, Leinster, Ireland
-
St James's Hospital
Dublin, Leinster, Ireland
-
University Hospital Limerick
Limerick, Munster, Ireland
Conditions
Explore the condition pages connected to this study.